» Articles » PMID: 30941103

Past, Present, and Future Strategies for Enhanced Assessment of Embryo's Genome and Reproductive Competence in Women of Advanced Reproductive Age

Overview
Specialty Endocrinology
Date 2019 Apr 4
PMID 30941103
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Recent advancements in genomic analysis allow testing of an increasing number of genetic features in human preimplantation embryos. Typical single gene mutation and whole chromosomes testing can now be integrated with assessment of mitochondrial DNA and polygenic conditions. Diagnostic expansion into epigenetic and transcriptomic assessment in the near future are potential technological targets which may improve the prognostic outlook of patients of advanced reproductive age and overall fertilization (IVF) treatment outcomes. In this review, we discuss the technological progress of recent years and their future applications in preimplantation genetic testing in IVF.

Citing Articles

Uniparental disomy (UPD) exclusion in embryos following Preimplantation Genetic Testing for Structural Rearrangements (PGT-SR).

Fabiani M, Margiotti K, Libotte F, Ali C, Zangheri C, Barone M J Assist Reprod Genet. 2024; 42(1):265-273.

PMID: 39693035 PMC: 11805737. DOI: 10.1007/s10815-024-03352-x.


Screening embryos for polygenic disease risk: a review of epidemiological, clinical, and ethical considerations.

Capalbo A, de Wert G, Mertes H, Klausner L, Coonen E, Spinella F Hum Reprod Update. 2024; 30(5):529-557.

PMID: 38805697 PMC: 11369226. DOI: 10.1093/humupd/dmae012.


Preimplantation genetic testing for embryos predisposed to hereditary cancer: Possibilities and challenges.

Albujja M, Al-Ghedan M, Dakshnamoorthy L, Pla Victori J Cancer Pathog Ther. 2024; 2(1):1-14.

PMID: 38328708 PMC: 10846329. DOI: 10.1016/j.cpt.2023.05.002.


Genetic counseling for pre-implantation genetic testing of monogenic disorders (PGT-M).

Parikh F, Athalye A, Madon P, Khandeparkar M, Naik D, Sanap R Front Reprod Health. 2024; 5:1213546.

PMID: 38162012 PMC: 10755023. DOI: 10.3389/frph.2023.1213546.


Effectiveness of non-invasive chromosomal screening for normal karyotype and chromosomal rearrangements.

Sun B, Wang Y, Sixi-Wen , Zhou L, Zhang C, Wu Z Front Genet. 2023; 14:1036467.

PMID: 36992701 PMC: 10040604. DOI: 10.3389/fgene.2023.1036467.


References
1.
Cohen J, Wells D, Munne S . Removal of 2 cells from cleavage stage embryos is likely to reduce the efficacy of chromosomal tests that are used to enhance implantation rates. Fertil Steril. 2006; 87(3):496-503. DOI: 10.1016/j.fertnstert.2006.07.1516. View

2.
Mastenbroek S, Twisk M, van Echten-Arends J, Sikkema-Raddatz B, Korevaar J, Verhoeve H . In vitro fertilization with preimplantation genetic screening. N Engl J Med. 2007; 357(1):9-17. DOI: 10.1056/NEJMoa067744. View

3.
Kader A, Choi A, Orief Y, Agarwal A . Factors affecting the outcome of human blastocyst vitrification. Reprod Biol Endocrinol. 2009; 7:99. PMC: 2757025. DOI: 10.1186/1477-7827-7-99. View

4.
Handyside A, Harton G, Mariani B, Thornhill A, Affara N, Shaw M . Karyomapping: a universal method for genome wide analysis of genetic disease based on mapping crossovers between parental haplotypes. J Med Genet. 2009; 47(10):651-8. DOI: 10.1136/jmg.2009.069971. View

5.
Treff N, Su J, Tao X, Levy B, Scott Jr R . Accurate single cell 24 chromosome aneuploidy screening using whole genome amplification and single nucleotide polymorphism microarrays. Fertil Steril. 2010; 94(6):2017-21. DOI: 10.1016/j.fertnstert.2010.01.052. View